Medical Oncology in Nebraska
11 providers, $757,592 in total reported payments from drug and device makers. Ranked below by lifetime general payments.
Ranking high here usually means a consulting or royalty arrangement, not wrongdoing. Payments to device inventors and trial investigators are legal, disclosed, and concentrated in a small number of people — which is exactly why a list like this has a steep top and a long flat tail.
What Medicare pays medical oncology clinicians in Nebraska
Across 11 medical oncology clinicians in Nebraska who billed Original Medicare Part B in 2024, Medicare allowed $5,698,167 in total — an average of $518,015 each, of which $116,497 was for services and the rest for drugs administered in the office.
This is not a salary. 78% of this figure is the cost of drugs administered in the office — chemotherapy, infusions and injections that Part B pays for and the practice has already bought. That money passes through; it is not earnings. The rest is what Medicare allowed for services these clinicians billed — Original Medicare fee-for-service only. It excludes Medicare Advantage, which now covers more than half of Medicare enrollees, along with Medicaid and every commercial insurer, so for most clinicians it is a fraction of their practice. It is also gross revenue: staff, rent, supplies and malpractice premiums all come out of it before anyone is paid. Anyone quoting a figure like this as physician pay is misreading it.
Ranked by reported payments
- 1Matthew LunningOmaha$631,139
- 2Jairam KrishnamurthyOmaha$63,108
- 3Benjamin TeplyOmaha$21,667
- 4Kelsey KluteOmaha$18,393
- 5Michael HaddadinOmaha$6,792
- 6Laxmi Narayana BuddharajuOmaha$6,643
- 7Haris ZahoorLincoln$6,118
- 8Nicole ShonkaOmaha$2,545
- 9Irfan VaziriLincoln$605
- 10Alissa MarrOmaha$319
- 11Lyudmyla BerimOmaha$263